Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, ...
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout ...
WASHINGTON — The Trump administration has dropped its nomination of Casey Means to be the next surgeon general, opting ...
On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical ...
Elevance Health is blocking the deposition of Peter Haytaian, an outgoing executive who previously oversaw the health insurer ...
ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the coverage.
A preclinical next-gen obesity drug is stacking five mechanisms (in mice). Also, the NIH funding climate is rougher than ever ...
AstraZeneca will resume expansion of its U.K. R&D operations after the trade deal with the U.S. included measures to lift U.K ...
The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of ...
FDA's plan to use AI to speed up trials, Hinge's new migraine device, and boosting cancer screening with texts.
A new social media narrative claims international grads are stealing American doctors’ jobs. These authors did the math to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results